论文部分内容阅读
为了解各类心脏病心衰患者有无洋地黄中毒发生,更合理地掌握用药剂量,我们对117例心衰患者服用地高辛(Digoxin)药物后进行了Digoxin浓度的动态检测,现报告如下。 对象和方法 一、对象: (一)本文117例(男48,女69)。均为我院住院病人,年龄1～80岁。 (二)病例分类:风心病70例、心肌病18例、冠心病13例、肺心病3例、先心病3例、高心病7例和甲心病1例,另2例为肾衰正在行血透病人。临床上多数采用Digoxin及西地兰合用。 二、方法:应用上海放射免疫分析技术研究所生产的Digoxin试剂盒,按说明书操作。测定仪器为上海日环厂生产的FMJ-182型γ-免疫计数器。
In order to understand whether there are any kinds of digitalis poisoning in heart failure patients of various types of heart disease and to master the dosage rationally, we conducted a dynamic test of Digoxin concentration in 117 patients with heart failure after taking Digoxin drug. . Objects and methods First, the object: (a) of this article 117 cases (male 48, female 69). Are hospitalized patients in our hospital, aged 1 to 80 years. (B) case classification: 70 cases of rheumatic heart disease, 18 cases of cardiomyopathy, coronary heart disease in 13 cases, 3 cases of cor pulmonale, 3 cases of congenital heart disease, 7 cases of heart disease and 1 case of heart disease, and the other 2 cases of renal failure are being blood Permeate people. Most clinical use of Digoxin and cedilanidate. Second, the method: Application of Shanghai Institute of Radioimmunoassay produced Digoxin kit, according to instructions. The measuring instrument is FMJ-182 type γ-immune counter produced by Shanghai Rihuan Plant.